Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.
- In-111-Octreotide Scintigraphy
- Somatostatin Therapy
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology